Articles of Journal of Japanese Medical Society for Lung Surfactant and Biological Interface | Volume 52, Issue / 2021

Search by Journal

HOME
> Search by Journal
> Journal of Japanese Medical Society for Lung Surfactant and Biological Interface

Journal of Japanese Medical Society for Lung Surfactant and Biological Interface

Volume 52, Issue / 2021

English Article

Japanese Article

Please note that metadata of J-type articlesare generated by machine-translation and the original texts are written in Japanese.

	Development of a trace antigen vaccine made possible by using the artificial synthetic adjuvant SF10 derived from pulmonary surfactant [Machine Translation] (肺サーファクタントに由来する人工合成アジュバントSF10を用いることで可能となった微量抗原ワクチン開発) 木戸博 Journal of Japanese Medical Society for Lung Surfactant and Biological Interface 52: 1-5, 2021.

Development of a trace antigen vaccine made possible by using the artificial synthetic adjuvant SF10 derived from pulmonary surfactant [Machine Translation] (肺サーファクタントに由来する人工合成アジュバントSF10を用いることで可能となった微量抗原ワクチン開発)
木戸博
Journal of Japanese Medical Society for Lung Surfactant and Biological Interface 52: 1-5, 2021.

	A very small amount of antigen vaccine development that became possible by using artificial composition Adjuvant SF10 which came from 1 pulmonary surfactant 木戸博 Journal of Japanese Medical Society for Lung Surfactant and Biological Interface 52: 7-7, 2021.

	From 2 Himalayas to Syria, the land of refugees 小松由佳 Journal of Japanese Medical Society for Lung Surfactant and Biological Interface 52: 8-10, 2021.

	Applied ... to process and surfactant clinical practice of 1 Osh Lome Tolly - development 黒澤一 Journal of Japanese Medical Society for Lung Surfactant and Biological Interface 52: 11-14, 2021.

	Where was the mechanism of 2 lungs fibrosis extension found to? 瀬戸口靖弘 Journal of Japanese Medical Society for Lung Surfactant and Biological Interface 52: 15-15, 2021.

	About a function and the structure of the antiGM-CSF autoantibody causing 3 autoimmune alveolar proteinosis 中田光 Journal of Japanese Medical Society for Lung Surfactant and Biological Interface 52: 16-16, 2021.

	Pulmonary protection strategy for 4 ARDS 中澤弘一 Journal of Japanese Medical Society for Lung Surfactant and Biological Interface 52: 17-24, 2021.

	1. Experience in treating alveolar proteinosis in our department 温麟太郎, 井形文保, 青山崇, 平野涼介, 井上博之, 藤田昌樹 Journal of Japanese Medical Society for Lung Surfactant and Biological Interface 52: 25-26, 2021.

	2. Droplet nuclei infection and pulmonary surfactant 多羅尾範郎 Journal of Japanese Medical Society for Lung Surfactant and Biological Interface 52: 27-28, 2021.

	3. Transport pathway of newly synthesized pulmonary surfactant protein B in alveolar type II epithelial cells 長内和弘1,2), 水野史朗2), 栂博久2), 高橋敬治2) Journal of Japanese Medical Society for Lung Surfactant and Biological Interface 52: 29-30, 2021.

	4. Usefulness of serum SP-A as the biomarker in COVID-19 pneumonia and SP-D 千葉弘文1), 齋藤充史1), 黒沼幸治1), 茂庭慶悟1), 高橋弘毅1,2) Journal of Japanese Medical Society for Lung Surfactant and Biological Interface 52: 31-31, 2021.

	5. Artificial composition mucous membrane Adjuvant SF-10 derived from pulmonary surfactant is the oral mucous membrane Adjuvant which can induce immunologic memory for an antiinfluenza long term for the infants period 木本貴士, 堺聡子, 亀田桂子, 森田涼子, 高橋悦久, 木戸博 Journal of Japanese Medical Society for Lung Surfactant and Biological Interface 52: 32-33, 2021.

	6. The control of the Th2 cytokine reply by Aquaporin5 and the pathophysiological significance 長田佳介, 藤川堪他, 礒濱洋一郎 Journal of Japanese Medical Society for Lung Surfactant and Biological Interface 52: 34-34, 2021.

	7. The condition of a patient formation of the bronchial asthma model mouse which we manufactured with a Chilean tick antigen and role of IL-17 for the steroid sensitivity 井原健1), 大野秀顕1), 岩倉洋一郎2), 礒濱洋一郎1) Journal of Japanese Medical Society for Lung Surfactant and Biological Interface 52: 35-35, 2021.

	8. Examination of the extension of a characteristic and the restrictive defect impairment of the MUC5B promoter seasonal polymorphism in the chronic hypersensitivity pneumonitis of this country 片柳真司, 岡本師, 瀬戸口靖弘, 宮崎泰成 Journal of Japanese Medical Society for Lung Surfactant and Biological Interface 52: 36-37, 2021.

	9. Analysis of osteopontin function in a mouse model of pulmonary fibrosis associated with SFTPC Non-BRICHOS domain mutation 濡木真一1), 平山文博1), 財津純可1), 河野崇史1), 平松和史1), 門田淳一1), J.Katzen2), S.Mulugeta2), M.F.Beers2) Journal of Japanese Medical Society for Lung Surfactant and Biological Interface 52: 38-38, 2021.

	10. Establishment of Csf2ra gene-deficient mice and verification as a model of hereditary alveolar proteinosis 島賢治郎1,2), 菊地利明1), Bruce Trapnell2), 鈴木拓児2,3) Journal of Japanese Medical Society for Lung Surfactant and Biological Interface 52: 39-40, 2021.

ID
Password